OVID
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Apr 24 closing price
Capitalization
23.94M
13 days until earnings call
TVTX
Price
$17.63
Change
+$0.93 (+5.57%)
Updated
Apr 24 closing price
Capitalization
1.57B
6 days until earnings call
Ad is loading...

OVID vs TVTX

Header iconOVID vs TVTX Comparison
Open Charts OVID vs TVTXBanner chart's image
Ovid Therapeutics
Price$0.34
Change+$0.02 (+6.25%)
Volume$768.73K
Capitalization23.94M
Travere Therapeutics
Price$17.63
Change+$0.93 (+5.57%)
Volume$1.43M
Capitalization1.57B
OVID vs TVTX Comparison Chart
Loading...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OVID vs. TVTX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OVID is a StrongBuy and TVTX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (OVID: $0.34 vs. TVTX: $17.63)
Brand notoriety: OVID and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OVID: 206% vs. TVTX: 82%
Market capitalization -- OVID: $23.94M vs. TVTX: $1.57B
OVID [@Biotechnology] is valued at $23.94M. TVTX’s [@Biotechnology] market capitalization is $1.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OVID’s FA Score shows that 1 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • OVID’s FA Score: 1 green, 4 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than OVID.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OVID’s TA Score shows that 4 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • OVID’s TA Score: 4 bullish, 4 bearish.
  • TVTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OVID is a better buy in the short-term than TVTX.

Price Growth

OVID (@Biotechnology) experienced а +16.70% price change this week, while TVTX (@Biotechnology) price change was +18.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

OVID is expected to report earnings on Aug 18, 2025.

TVTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($1.57B) has a higher market cap than OVID($23.9M). TVTX YTD gains are higher at: 1.206 vs. OVID (-63.928). OVID has higher annual earnings (EBITDA): -61.27M vs. TVTX (-265.77M). TVTX has more cash in the bank: 371M vs. OVID (53.1M). OVID has less debt than TVTX: OVID (14.8M) vs TVTX (402M). TVTX has higher revenues than OVID: TVTX (233M) vs OVID (566K).
OVIDTVTXOVID / TVTX
Capitalization23.9M1.57B2%
EBITDA-61.27M-265.77M23%
Gain YTD-63.9281.206-5,303%
P/E RatioN/AN/A-
Revenue566K233M0%
Total Cash53.1M371M14%
Total Debt14.8M402M4%
FUNDAMENTALS RATINGS
OVID vs TVTX: Fundamental Ratings
OVID
TVTX
OUTLOOK RATING
1..100
412
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
86
Overvalued
PROFIT vs RISK RATING
1..100
10084
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
9643
P/E GROWTH RATING
1..100
9338
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OVID's Valuation (31) in the Pharmaceuticals Major industry is somewhat better than the same rating for TVTX (86) in the Biotechnology industry. This means that OVID’s stock grew somewhat faster than TVTX’s over the last 12 months.

TVTX's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as OVID (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to OVID’s over the last 12 months.

OVID's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as TVTX (98) in the Biotechnology industry. This means that OVID’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for OVID (96) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew somewhat faster than OVID’s over the last 12 months.

TVTX's P/E Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for OVID (93) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew somewhat faster than OVID’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OVIDTVTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 22 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HBIOX17.50N/A
N/A
Hartford International Opp HLS IB
FLPSX38.97N/A
N/A
Fidelity Low-Priced Stock
FSAVX52.97N/A
N/A
Fidelity Select Automotive Port
TINCX2.48N/A
N/A
Templeton Global Balanced A1
CBHCX8.53N/A
N/A
Victory Market Neutral Income C

OVID and

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with AVTE. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then AVTE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+3.63%
AVTE - OVID
88%
Closely correlated
-0.73%
SYRE - OVID
46%
Loosely correlated
+4.99%
NAUT - OVID
36%
Loosely correlated
-3.92%
KPRX - OVID
36%
Loosely correlated
+2.56%
TVTX - OVID
36%
Loosely correlated
+5.57%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+5.57%
CRNX - TVTX
41%
Loosely correlated
+3.15%
BHVN - TVTX
41%
Loosely correlated
+9.24%
COGT - TVTX
39%
Loosely correlated
+0.89%
RLAY - TVTX
39%
Loosely correlated
+2.57%
XNCR - TVTX
39%
Loosely correlated
-0.28%
More